Overview Flu can be serious and lead to hospitalization or death. Flu vaccination is the best way to protect against flu. Between 140,000 and 710,000 people were hospitalized with flu each year during 2010–2020. People from some racial and ethnic minority groups are more likely to be hospitalized with flu. […]
JYNNEOS vaccine is licensed as a series of two doses administered 28 days (4 weeks) apart. The standard regimen involves a subcutaneous (Subcut) route of administration with an injection volume of 0.5mL. The standard regimen is the FDA-approved dosing regimen. Since August 9, 2022, the standard regimen has been authorized for people […]
The benefits of maternal vaccination to the infant through maternal antibody transfer across the placenta have long been recognized. In the 1870s, babies born to mothers who had received smallpox vaccination were unlikely to have smallpox early in life.1 Tetanus toxoid vaccination during pregnancy, along with improved hygiene during delivery, has […]
The risk of developing myocarditis and other inflammatory heart conditions after COVID-19 vaccination is substantially lower than it is after SARS-CoV-2 infection, according to an analysis of electronic health records from 40 US health systems. Although it’s a rare complication, myocarditis has been associated with both SARS-CoV-2 infection and messenger RNA (mRNA)–based […]
New data from two different sources on cardiac complications linked to COVID-19 have shown that such issues are low overall, but are higher after infection than after vaccination. The new information comes from the Centers for Disease Control and Prevention’s (CDC’s) National Patient-Centered Clinical Research Network (PCORnet), and from a separate […]
Summary What is already known about this topic? Persons with previous SARS-CoV-2 infection have some protection against reinfection leading to hospitalization, but there is limited evidence regarding the additional benefit of vaccination among these persons. What is added by this report? Among persons with previous infection, COVID-19 mRNA vaccination provided […]
The timing of treatment in relation to vaccination is the strongest predictor of COVID-19 vaccine antibody response say the researchers of a new study. For their study, published in Nature Cancer, researchers from the University of Southampton led a UK multicentre prospective observational study (PROSECO) evaluating COVID-19 vaccine responses in individuals with […]
A new study finds no increased risk of rare neurological events after COVID-19 vaccination, but does find an increased risk of these events after SARS-CoV-2 infection. The European Medicines Agency (EMA) listed Guillain-Barré syndrome as a rare side effect of the Oxford-AstraZeneca and Pfizer-BioNTech COVID vaccines following reports that some […]
A real-world, prospective study in a secondary school system showed risk for symptomatic infection to be 9 times higher in unvaccinated children. Recent surveys suggest that many parents are reluctant to permit SARS-CoV-2 vaccination for their school-aged children. In this study, researchers in North Carolina used a private secondary school […]
Summary What is already known about this topic? COVID-19 incidence and mortality are higher in rural than in urban communities. Disparities in COVID-19 vaccination coverage between urban and rural communities have been recognized. What is added by this report? COVID-19 vaccination coverage with the first dose of the primary vaccination […]
